Lentivirus-mediated overexpression of TGF-β inducible early gene 1 inhibits SW1990 pancreatic cancer cell growth

Cell Biology International

Volumn 35, Issue 9, 2011, Pages 891-896

  Jiang, Lei ^a   Wang, Fule ^a   Lin, Feiyan ^a   Gao, Shen Meng ^a   Tan, Yingxia ^a   Han, Yixiang ^a   Chen, Chiqi ^a   Wu, Jianbo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Lentivirus; Pancreatic cancer; TIEG1; Tumourigenicity

Indexed keywords

LENTIVIRUS VECTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE EARLY GENE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; MALE; MOUSE; NONHUMAN; ONCOGENE; PANCREAS CANCER; SIGNAL TRANSDUCTION; TARGET CELL; TIEG 1 ONCOGENE; TUMOR CELL; TUMOR XENOGRAFT; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LENTIVIRUS; MALE; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; RNA, MESSENGER; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

LENTIVIRUS; MUS MUSCULUS;

EID: 79961102768     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100896     Document Type: Article

References (22)

1. Chalaux E, Lopez-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, et al. A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett 1999;457:478-82.
2. Chrisman HR, Tindall DJ. Identification and characterization of a consensus DNA binding element for the zinc finger transcription factor TIEG/EGRalpha. DNA Cell Biol 2003;22:187-99.
3. Connolly JB. Lentiviruses in gene therapy clinical research. Gene Ther 2002;9:1730-4.
4. Cook T, Urrutia R. TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth. Am J Physiol Gastrointest Liver Physiol 2000;278:G513-21.
5. Copreni E, Penzo M, Carrabino S, Conese M. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther 2004;11 Suppl 1:S67-75.
6. DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A, et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2010;2:36ra43.
7. Duffy JP, Eibl G, Reber HA, Hines OJ. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2003;2:12.
8. Fautsch MP, Vrabel A, Rickard D, Subramaniam M, Spelsberg TC, Wieben ED. Characterization of the mouse TGFbeta-inducible early gene (TIEG): conservation of exon and transcriptional regulatory sequences with evidence of additional transcripts. Mamm Genome 1998;9:838-42.
9. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
10. Jiang L, Chen Y, Chan CY, Wang X, Lin L, He ML, et al. Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells. Cancer Lett 2009;274:101-8.
11. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
12. Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, et al. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer. Surgery 2006;140:149-60.
13. Mimeault M, Brand RE, Sasson AA, Batra SK. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas 2005;31:301-16.
14. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995;76:1671-7.
15. Rane SG, Lee JH, Lin HM. Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. Cytokine Growth Factor Rev 2006;17:107-19.
16. Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, et al. Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Res Treat 2004;86:75-88.
17. Reni M, Pasetto L, Aprile G, Cordio S, Bonetto E, Dell'Oro S, et al. Raltitrexed-eloxatin salvage chemotherapy in gemcitabineresistant metastatic pancreatic cancer. Br J Cancer 2006;94:785-91.
18. Ribeiro A, Bronk SF, Roberts PJ, Urrutia R, Gores GJ. The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology 1999;30:1490-7.
19. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999;189:1-7.
20. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 1995;23:4907-12.
21. Subramaniam M, Hefferan TE, Tau K, Peus D, Pittelkow M, Jalal S, et al. Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J Cell Biochem 1998;68:226-36.
22. Sumimoto H, Kawakami Y. The RNA silencing technology applied by lentiviral vectors in oncology. Methods Mol Biol 2010;614:187-99